• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用因子分析对亚临床动脉粥样硬化和心血管风险增加患者的危险因素进行分析。

Analysis of Risk Factors in Patients with Subclinical Atherosclerosis and Increased Cardiovascular Risk Using Factor Analysis.

作者信息

Pella Zuzana, Pella Dominik, Paralič Ján, Vanko Jakub Ivan, Fedačko Ján

机构信息

Department of Cybernetics and Artificial Intelligence, Faculty of Electrical Engineering and Informatics, Technical University of Košice, 040 01 Košice, Slovakia.

1st Department of Cardiology, East Slovak Institute for Cardiovascular Diseases, 040 01 Košice, Slovakia.

出版信息

Diagnostics (Basel). 2021 Jul 16;11(7):1284. doi: 10.3390/diagnostics11071284.

DOI:10.3390/diagnostics11071284
PMID:34359367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8307184/
Abstract

Today, there are many parameters used for cardiovascular risk quantification and to identify many of the high-risk subjects; however, many of them do not reflect reality. Modern personalized medicine is the key to fast and effective diagnostics and treatment of cardiovascular diseases. One step towards this goal is a better understanding of connections between numerous risk factors. We used Factor analysis to identify a suitable number of factors on observed data about patients hospitalized in the East Slovak Institute of Cardiovascular Diseases in Košice. The data describes 808 participants cross-identifying symptomatic and coronarography resulting characteristics. We created several clusters of factors. The most significant cluster of factors identified six factors: basic characteristics of the patient; renal parameters and fibrinogen; family predisposition to CVD; personal history of CVD; lifestyle of the patient; and echo and ECG examination results. The factor analysis results confirmed the known findings and recommendations related to CVD. The derivation of new facts concerning the risk factors of CVD will be of interest to further research, focusing, among other things, on explanatory methods.

摘要

如今,有许多参数用于心血管风险量化以及识别众多高危人群;然而,其中许多参数并不能反映实际情况。现代个性化医疗是快速有效诊断和治疗心血管疾病的关键。朝着这一目标迈出的一步是更好地理解众多风险因素之间的联系。我们使用因子分析从在科希策的东斯洛伐克心血管疾病研究所住院患者的观测数据中确定合适数量的因子。该数据描述了808名参与者交叉识别的症状和冠状动脉造影结果特征。我们创建了几个因子簇。最显著的因子簇确定了六个因子:患者的基本特征;肾脏参数和纤维蛋白原;心血管疾病的家族易感性;心血管疾病个人史;患者的生活方式;以及超声心动图和心电图检查结果。因子分析结果证实了与心血管疾病相关的已知发现和建议。关于心血管疾病风险因素新事实的推导将引起进一步研究的兴趣,并将重点关注解释方法等方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/e74cf4e9e9c9/diagnostics-11-01284-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/f51f92d94125/diagnostics-11-01284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/8684166a7fe7/diagnostics-11-01284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/738279f00949/diagnostics-11-01284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/8b21269bda17/diagnostics-11-01284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/f39d8e2cfca7/diagnostics-11-01284-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/70bd4f181cf4/diagnostics-11-01284-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/c6e72f4a3a6e/diagnostics-11-01284-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/aeb1a8206bb3/diagnostics-11-01284-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/86611c1a63af/diagnostics-11-01284-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/fc93fe8f970b/diagnostics-11-01284-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/e74cf4e9e9c9/diagnostics-11-01284-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/f51f92d94125/diagnostics-11-01284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/8684166a7fe7/diagnostics-11-01284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/738279f00949/diagnostics-11-01284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/8b21269bda17/diagnostics-11-01284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/f39d8e2cfca7/diagnostics-11-01284-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/70bd4f181cf4/diagnostics-11-01284-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/c6e72f4a3a6e/diagnostics-11-01284-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/aeb1a8206bb3/diagnostics-11-01284-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/86611c1a63af/diagnostics-11-01284-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/fc93fe8f970b/diagnostics-11-01284-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4b1/8307184/e74cf4e9e9c9/diagnostics-11-01284-g011.jpg

相似文献

1
Analysis of Risk Factors in Patients with Subclinical Atherosclerosis and Increased Cardiovascular Risk Using Factor Analysis.运用因子分析对亚临床动脉粥样硬化和心血管风险增加患者的危险因素进行分析。
Diagnostics (Basel). 2021 Jul 16;11(7):1284. doi: 10.3390/diagnostics11071284.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.踝臂指数作为心血管健康研究中动脉粥样硬化的标志物。心血管健康研究(CHS)协作研究组。
Circulation. 1993 Sep;88(3):837-45. doi: 10.1161/01.cir.88.3.837.
4
Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?亚临床动脉粥样硬化、心血管健康与疾病风险:心血管健康指数是否适用于一级预防人群?
BMC Public Health. 2018 Apr 2;18(1):429. doi: 10.1186/s12889-018-5263-6.
5
Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.纤维蛋白原和凝血因子VIII而非凝血因子VII与老年人亚临床心血管疾病的指标相关。心血管健康研究的结果。
Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1269-79. doi: 10.1161/01.atv.15.9.1269.
6
Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.成纤维细胞生长因子 21 与亚临床动脉粥样硬化和心血管事件的关系:动脉粥样硬化多民族研究。
Atherosclerosis. 2019 Aug;287:46-53. doi: 10.1016/j.atherosclerosis.2019.06.898. Epub 2019 Jun 8.
7
Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future.自身免疫性风湿疾病背景下心血管风险的新型替代标志物:当前数据及对未来的启示
Front Med (Lausanne). 2022 Jun 30;9:820263. doi: 10.3389/fmed.2022.820263. eCollection 2022.
8
Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study.尼日利亚中北部乔斯市 HIV 感染成年人亚临床动脉粥样硬化及相关危险因素:一项横断面研究。
Pan Afr Med J. 2020 Dec 31;37:388. doi: 10.11604/pamj.2020.37.388.21073. eCollection 2020.
9
The possible role of machine learning in detection of increased cardiovascular risk patients - KSC MR Study (design).机器学习在检测心血管风险增加患者中的潜在作用——KSC磁共振研究(设计)
Arch Med Sci. 2020 Sep 21;18(4):991-997. doi: 10.5114/aoms.2020.99156. eCollection 2022.
10
Increased knowledge makes a difference! - general practitioners' experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial.知识就是力量!——全科医生对亚临床动脉粥样硬化初级预防的图片信息的体验:来自 VIPVIZA 试验的访谈研究。
Scand J Prim Health Care. 2021 Mar;39(1):77-84. doi: 10.1080/02813432.2021.1882083. Epub 2021 Feb 11.

引用本文的文献

1
Genetic Variants of , May Impact the Risk for the Onset of Coronary Artery Disease in the Pakistani Population.的遗传变异可能会影响巴基斯坦人群冠心病发病的风险。
Genes (Basel). 2022 Apr 24;13(5):747. doi: 10.3390/genes13050747.

本文引用的文献

1
The possible role of machine learning in detection of increased cardiovascular risk patients - KSC MR Study (design).机器学习在检测心血管风险增加患者中的潜在作用——KSC磁共振研究(设计)
Arch Med Sci. 2020 Sep 21;18(4):991-997. doi: 10.5114/aoms.2020.99156. eCollection 2022.
2
Factor analysis for the clustering of cardiometabolic risk factors and sedentary behavior, a cross-sectional study.对心血管代谢风险因素和久坐行为进行聚类的因子分析:一项横断面研究。
PLoS One. 2020 Nov 16;15(11):e0242365. doi: 10.1371/journal.pone.0242365. eCollection 2020.
3
The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases.
临床决策支持系统在预防、诊断和监测过敏性疾病方面的潜力。
Front Immunol. 2020 Sep 10;11:2116. doi: 10.3389/fimmu.2020.02116. eCollection 2020.
4
Inherent Bias in Artificial Intelligence-Based Decision Support Systems for Healthcare.人工智能在医疗保健决策支持系统中的固有偏差。
Medicina (Kaunas). 2020 Mar 20;56(3):141. doi: 10.3390/medicina56030141.
5
Impact of Hospital Practice Factors on Mortality in Patients Hospitalized for Heart Failure in Japan - An Analysis of a Large Number of Health Records From a Nationwide Claims-Based Database, the JROAD-DPC.日本心力衰竭住院患者死亡率与医院实践因素的关系分析——基于全国基于索赔的数据库 JROAD-DPC 的大量健康记录分析。
Circ J. 2020 Apr 24;84(5):742-753. doi: 10.1253/circj.CJ-19-0759. Epub 2020 Apr 2.
6
Should we admit more patients not requiring invasive ventilation to reduce excess mortality in Polish intensive care units? Data from the Silesian ICU Registry.我们是否应该收治更多不需要有创通气的患者以降低波兰重症监护病房的超额死亡率?来自西里西亚重症监护病房登记处的数据。
Arch Med Sci. 2019 Sep;15(5):1313-1320. doi: 10.5114/aoms.2019.84401. Epub 2019 May 8.
7
Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence.稳定型心绞痛药物治疗管理指南:对欧洲心脏病学会和英国国家卫生与临床优化研究所指南的批判性综述
Eur Cardiol. 2019 Apr;14(1):18-22. doi: 10.15420/ecr.2018.26.1.
8
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.冠心病患者血脂异常的管理:来自 27 个国家的 ESC-EORP EUROASPIRE V 调查结果。
Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24.
9
Fibrinogen and fibrin: An illustrated review.纤维蛋白原与纤维蛋白:图文综述
Res Pract Thromb Haemost. 2019 Mar 4;3(2):161-172. doi: 10.1002/rth2.12191. eCollection 2019 Apr.
10
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.维生素 D 缺乏症患者的舒张功能障碍或射血分数保留型心力衰竭。
ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.